Diabetes Information [Return To Home Page]

Diabetic Complications - Can Benfotiamine Help Prevent Them?


Diabetic complications contribute too many life threatening diseases globally. The root cause of diabetic complications is elevated glucose levels which contribute to blood vessel damage. Diabetic retinopathy, nephropathy, or neuropathy are caused by damage to small blood vessel in the eyes, nerves and kidneys, etc. The bottom line of this damage is the lowering of the life expectancy of millions of diabetics worldwide.

What Can Be Done About It?

Few therapies are available today that treat diabetic complications. Most healthcare professionals recommend that their patients monitor their blood sugar by taking several blood readings a day to determine the amount of sugar in their blood. Blood sugar readings are generally higher from one to two hours after a meal.

It is suggested by these professionals that keeping blood sugar readings as close to normal as possible will reduce the onset of diabetic complications. Research has shown that there are four, chemical pathways that lead to diabetic complications. Instead of trying to explain these rather difficult chemical pathways, let the reader understand that diabetic complications are mainly caused by excess sugar in the cells, a condition known by the term advanced glycation endproducts (AGE) formation.

The research that was released in 2003 by a team of researchers from the Albert Einstein Collage of Medicine opened the possibilities that it may be possible to actually prevent and/or contain diabetic complications such as retinopathy, neuropathy and heart/circulatory conditions brought about by the presence of advanced glycation endproducts.

What Did This Research Suggest?

The Einstein researchers' work showed that a substance called, "benfotiamine", could reduce the effects of AGE by increasing the amount of an enzyme called transketolase. The research indicated that transketolase was increased by 300% which was enough to make a serious reduction of three of the four chemical pathways that open the door for diabetic complications in terms of vascular damage in diabetics. This vascular damage is directly responsible for the diabetic complications such as neuropathy, retinopathy and heart/circulatory conditions that lead to heart attack and stroke.

Can Benfotaimine Be Considered A Prudent Preventative?

Current research suggests that benfotiamine could possibly reduce the chances of diabetics developing the aforementioned complications. Many healthcare professionals readily recommend patients to add this nutritional supplement to their toolkit in the battle to prevent these insidious conditions that shorten the lives of thousands of diabetics annually.

Where Can I Find More Information About Benfotiamine?

More information about benfotiamine can be found by visiting the web site below and following the links. These links will give the reader a good base to make an informed decision about the use of benfotiamine in the battle against diabetic complications brought about by the presence of advanced glycation endproducts (AGE) which is excess sugar in the blood.

Research:

Hans-Peter Hammes, Xueliang Du, Diane Edelstein, Tetsuya Taguchi, Takeshi Matsumura, Qida Ju, Jihong Lin, Angelika Bierhaus, Peter Nawroth, Dieter Hannak, Michael Neumaier, Regine Bergfeld, Ida Giardino, Michael Brownlee. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Medicine 9, 294 - 299 (01 Mar 2003).

Michael Brownlee. Biochemistry and molecular cell biology of diabetic complications Nature 414, 813 - 820 (13 Dec 2001).

Roya Babaei-Jadidi, Nikolaos Karachalias, Naila Ahmed, Sinan Battah, Paul J. Thornalley. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine - Complications. Diabetes. (August 2003).

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:


TopNews United States

Novartis drugs fail to prevent diabetes in the overweight
Xinhua
BEIJING, March 15 (Xinhuanet) -- Novartis AG's (NVS) two drugs have failed to prevent diabetes and the problems it causes in the overweight with poor sugar ...
Drugs in pre-diabetics do little to slow progression to diabetes or to heart ...Los Angeles Times (blog)
Search for Better Diabetes Therapy Falls ShortWall Street Journal
Soy products beat drugs for type 2 diabetes prevention?Food Consumer
BusinessWeek -TopNews United States -Visit Bulgaria
all 20 news articles »


FDA wants label information on diabetes injection
MarketWatch
Byuderon is a once-weekly formulation of exenatide, the active ingredient in Byetta which is used in Type 2 diabetes. In the complete response letter, ...
Byetta LARS: How the FDA's Analysis Paralysis May Aid AmylinSeeking Alpha (blog)
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for ...PR Newswire (press release)
FDA finds flaws at Amylin plantCincinnati Business Courier
Financial News USA (press release)
all 18 news articles »


Forbes (blog)

No heart benefit seen with fibrates in diabetics
Reuters
The study run by the National Institutes of Health, dubbed Accord, aimed to see if the dual-drug therapy could reduce cardiovascular events in diabetes ...
Abbott's TriCor Shows No Benefit For Diabetics In StudyWall Street Journal
Abbott's TriCor With Statin Fails to Cut Diabetic Heart RiskBusinessWeek
ACC: FDA Announces Review of ACCORD DataMedPage Today
Forbes (blog) -PR Newswire (press release) -Benzinga
all 69 news articles »


BBC News

No quick drug fix for high diabetes risk
BBC News
Two key treatments do not halt diabetes in people with early signs of the disease, a large study has found. Researchers said the results showed the only way ...
Workplace fruit - helping keep your diet on trackFruitful Office - Office Fruit News Site (blog)

all 7 news articles »


Effect of Valsartan/Nateglinide on the Incidence of Diabetes and ...
Cardiosource
Study Question: Does use of short-acting insulin secretagogues and/or rennin-angiotensin-blockers reduce the risk of diabetes or cardiovascular (CV) events ...
NAVIGATOR: Valsartan slowed progression to diabetes, no effect on CV eventsEndocrine Today
Navigating the Choices for Diabetes PreventionNew England Journal of Medicine (subscription)
ACC: NAVIGATOR Confirms Diet and Exercise Still BestMedPage Today
RTT News -PR-inside.com (press release)
all 22 news articles »


Swiss stocks - Factors to watch on March 15
Reuters
The diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and ...

and more »


Psychologist helps people cope with diabetes
GoErie.com
D., a psychologist who focuses on helping people with diabetes cope with the stress of having the disease. Studies have shown that people with diabetes have ...
Psychologist helps people cope with diabetesGoErie.com

all 2 news articles »


KolkataObserver.com

Aggressive BP control not effective, possibly harmful, in patients with diabetes
Endocrine Today
ATLANTA – Tight systolic blood pressure control in high-risk patients with diabetes appears to be no more effective in avoiding myocardial infarction, ...
Study: 'Ideal' Blood Pressure Level May Be Too Low For DiabeticsAHN | All Headline News
ACC: Pushing Blood Pressure Too Low May be HarmfulMedPage Today
INVEST: Mortality hazard with lowest blood pressures in diabetics with CAD?TheHeart.Org

all 22 news articles »


Lowering BP risky for patients with diabetes, heart disease
Sify
A University of Florida researcher has urged caution in reducing blood pressure in patients with diabetes and coronary disease. ...


Google News






home | site map
© 2006